LanceSoft, Inc. · 1 month ago
Cytotechnologist - Sign-on bonus of $5K - Relocation assistance of $2K
LanceSoft, Inc. is one of the largest staffing firms in the US, and they are seeking a Cytotechnologist responsible for processing and screening cytologic specimens. The role involves performing microscopic evaluations, issuing diagnostic reports, and ensuring specimen quality while maintaining regulatory compliance.
Information Technology
Responsibilities
Process and screen cytologic specimens according to established procedures
Perform microscopic evaluation and issue diagnostic reports
Finalize negative GYN case reports; provide preliminary findings for other cases
Conduct and document quality control and quality assurance activities
Assist and ensure accuracy of fine needle aspiration (FNA) procedures
Maintain patient specimen identification and ensure accurate processing
Follow infection control and safety standards consistently
Contribute to efficient operations and adjust schedule based on workload
Qualification
Required
BS/BA in Cytotechnology, Biology, or Life Sciences
Completion of an accredited Cytotechnology program
Cytotechnologist (CT) ASCP or equivalent certification
Strong communication and listening skills
Technical proficiency and attention to detail
Ability to work collaboratively in a team environment
Availability for first-shift, Monday–Friday
Benefits
Sign-on Bonus: Up to $5,000
Out-of-State Relocation Assistance: $2,000
Company
LanceSoft, Inc.
Established in 2000, LanceSoft is a pioneer in delivering top-notch Global Workforce Solutions and IT Services to a diverse clientele.
H1B Sponsorship
LanceSoft, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (55)
2024 (32)
2023 (23)
2022 (25)
2021 (60)
2020 (80)
Funding
Current Stage
Late StageCompany data provided by crunchbase